American Journal of Obstetrics & Gynecology
Volume 191, Issue 2 , Pages 398-407 , August 2004

Prescription drug use in pregnancy

Received 29 October 2003 ,Revised 1 April 2004 ,Accepted 21 April 2004.

References 

  1. Haramburu F, Miremont-Salame G, Moore N. Good and bad prescription in pregnancy. Lancet. 2000;356:1704
  2. Olesen C, Steffensen FH, Nielsen GL, de Jong-van den Berg L, Olsen J, Sorensen HT, et al. Drug use in first pregnancy and lactation: a population-based survey among Danish women. Eur J Clin Pharmacol. 1999;55:139–144
  3. Rubin JD, Ferencz C, Loffredo C, the Baltimore-Washington Infant Study Group . Use of prescription and non-prescription drugs in pregnancy. J Clin Epidemiol. 1993;46:581–589
  4. Brocklebank JC, Ray WA, Federspiel CF, Schaffner W. Drug prescribing during pregnancy: a controlled study of Tennessee Medicaid recipients. Am J Obstet Gynecol. 1978;132:235–244
  5. Piper JM, Baum C, Kennedy DL. Prescription drug use before and during pregnancy in a Medicaid population. Am J Obstet Gynecol. 1987;157:148–156
  6. Buitendijk S, Bracken MB. Medication in early pregnancy: prevalence of use and relationship to maternal characteristics. Am J Obstet Gynecol. 1991;165:33–40
  7. Piper JM, Baum C, Kennedy DL, Price P. Maternal use of prescribed drugs associated with recognized fetal adverse drug reactions. Am J Obstet Gynecol. 1988;159:1173–1177
  8. Bonati M, Bortolus R, Marchetti F, Romero M, Tognoni G. Drug use in pregnancy: an overview of epidemiological (drug utilization) studies. Eur J Clin Pharmacol. 1990;38:325–328
  9. Collaborative Group on Drug Use in Pregnancy . Medication during pregnancy: an intercontinental cooperative study. Int J Gynecol Obstet. 1992;39:185–196
  10. Donati S, Baglio G, Spinelli A, Grandolfo ME. Drug use in pregnancy among Italian women. Eur J Clin Pharmacol. 2000;56:323–328
  11. Lacroix I, Damase-Michel C, Lapeyre-Mestre M, Montastruc JL. Prescription of drugs during pregnancy in France. Lancet. 2000;356:1735–1736
  12. Olesen C, Sorensen HT, de Jong-van den Berg L, Olsen J, Steffensen FH, the Euromap Group . Prescribing during pregnanacy and lactation with reference to the Swedish classification system: a population-based study among Danish women. Acta Obstet Gynecol Scand. 1999;78:686–692
  13. Classification of medicinal products for use during pregnancy and lactation: the Swedish systems. Kungsbacka, Sweden: LINFO, Drug Information Ltd; 1993;
  14. Briggs GG, Freeman RK, Yaffe SJ. A reference guide to fetal and neonatal risk- drugs in pregnancy and lactation. 5th ed.. Philadephia: Lippincott Williams & Wilkins; 1998;
  15. Splinter MY, Sagraves R, Nightengale B, Rayburn WF. Prenatal use of medications by women giving birth at a university hospital. South Med J. 1997;90:498–502
  16. Doering PL, Boothby LA, Cheok M. Review of pregnancy labeling of prescription drugs: Is the current system adequate to inform of risks?. Am J Obstet Gynecol. 2002;187:333–339
  17. In:  Shojania K,  Duncan B,  McDonald K,  Wachter RM editor. Making health care safer: a critical analysis of patient safety practices. Evidence report/technology assessment no. 43; AJRQ publication 01-E058. Rockville (MD): Agency for Healthcare Research and Quality; 2001;

☆ Supported by grant HS10391 from the Agency for Healthcare Research and Quality to The HMO Research Network Center for Education and Research in Therapeutics (CERT).

PII: S0002-9378(04)00420-X

doi: 10.1016/j.ajog.2004.04.025

American Journal of Obstetrics & Gynecology
Volume 191, Issue 2 , Pages 398-407 , August 2004

Article Tools